Corium Announces Proposed Public Offering of Common Stock
May 24, 2017 20:11 pm UTC| Business
MENLO PARK, Calif., May 24, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
Corium Announces Proposed Public Offering of Common Stock
May 24, 2017 20:11 pm UTC| Business
MENLO PARK, Calif., May 24, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
Corium Announces Proposed Public Offering of Common Stock
May 24, 2017 20:11 pm UTC| Business
MENLO PARK, Calif., May 24, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
Corium Announces Proposed Public Offering of Common Stock
May 24, 2017 20:11 pm UTC| Business
MENLO PARK, Calif., May 24, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
Corium Announces Proposed Public Offering of Common Stock
May 24, 2017 20:11 pm UTC| Business
MENLO PARK, Calif., May 24, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
Corium Announces Proposed Public Offering of Common Stock
May 24, 2017 20:11 pm UTC| Business
MENLO PARK, Calif., May 24, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
Corium Announces Proposed Public Offering of Common Stock
May 24, 2017 20:11 pm UTC| Business
MENLO PARK, Calif., May 24, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...